 the arterial tubing circuit and across a
filter before it reenters the venous circulation. As FDA approval for the device was delivered
in 2016, the technology is less than 10 years old without robust long-term follow up data.
This technique offers a lower perioperative stroke risk than transfemoral stenting, for multiple
reasons including lack of transaortic arch manipulation and great vessel cannulation which can
result in embolus prior to placement of an